Abstract
Background Antibody titration and the life span of the antibody against SARS-CoV-2 have been found to be determined by the clinical presentation as well. The extent of exposure of health care workers and the general public to SARS-CoV-2 needs to be assessed to monitor the COVID-19 pandemic. Thus, this study is an attempt in assessing the anti-SARs-COV-2 antibody in health care workers.
Methods This laboratory-based cross-sectional study was performed in Manmohan Memorial Medical College and Teaching Hospital, Kathmandu from November 2020 to January 2021. A total of 185 HCWs were screened for anti-SARS-CoV-2 antibody in the blood serum specimens. A structured questionnaire was administered to collect information from HCWs. Anti-SARS- CoV-2 antibody screening was performed using a lateral flow immunoassay. Data were analyzed according to standard statistical methods using SPSS version 20.
Results A total of 185 HCWs were participated in the study, among which 41 (22.2%) of them tested positive for anti-SARS-CoV-2 antibody. Among the 41 individuals who tested positive, 37 of them tested positive for IgG only and 4 of them tested positive for both IgM and IgG antibodies. Presence of history of SARS-CoV-2 infection (p<0.001), presence of flu-like symptoms within the last 6 months (p<0.001), and presence of positive contact history (p=0.002) were statistically significant with antibody screening among HCWs.
Conclusion The burden of SARS-CoV-2 infection among healthcare workers seems to be high and HCWs are at risk of acquiring infection in the workplace. Anti-SARS-CoV-2 antibody screening among health care workers is highly recommended in multiple healthcare settings that can help in monitoring transmission dynamics and evaluation of infection control policies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no funding for the study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research work was approved by the Institutional Review Committee of Manmohan Memorial Institute of Health Sciences (MMIHS-IRC 491), Kathmandu, Nepal.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Co-authors and email:- Suraj Aryal- aryanaryal50{at}gmail.com
Sanskriti Pandit- sanskritipandit8{at}gmail.com
Sushant Pokhrel-sushant.pokhrel{at}mmihs.edu.np
Mandira Chhusyabaga- mandira.chhusyabaga{at}gmail.com
Pabitra Bista- pabitra.bista311{at}gmail.com
Dr. Mahendra Psd. Bhatt- mahendra.bhatt{at}mmihs.edu.np
Dr. Dharma Datta Subedi-dharma_subedi{at}hotmail.com
Data Availability
All data generated during this study are presented in this paper. The primary raw data will be made available to interested researchers by the first author (aryanaryal50@gmail.com) if requested
Abbreviations
- SARS-CoV-2
- Sub Acute Respiratory Syndrome Corona Virus 2
- COVID-19
- Coronavirus Disease 2019
- WHO
- World Health Organization
- HCWs
- Health Care Workers
- MMTH
- Manmohan Memorial Medical College and Teaching Hospital
- SPSS
- Statistical Package for Social Sciences
- IQR
- Inter Quartile Range
- ELISA
- Enzyme Linked Immuno-sorbent Assay
- CLIA
- Chemiluminescence Immunoassay
- PPE
- Personal Protective Equipment
